T lymphocyte activation requires recognition of antigen by the antigen
specific TCR as well as second co-stimulatory signals. This recogniti
on event results in the activation of non-TCR linked protein tyrosine
kinases (PTKs). The mechanism of co-stimulation of T cells is unknown
except for the involvement of PTKs. The T cell surface molecule CD28 i
s effective in delivering co-stimulatory signals and prevents T cell a
nergy by inducing T cell proliferation in TCR stimulated T cells, prim
arily due to an increase in IL-2 production. The mechanism by which CD
28 mediates this effect is currently unknown. Some conventional recept
or molecules possess intrinsic tyrosine kinase and as a consequence of
cross-linking or ligand binding, phosphorylate numerous tyrosines wit
hin their cytoplasmic tall, leading these tyrosines to become 'activat
ed' and bind cytoplasmic effector molecules possessing Src homology 2
domains which specifically recognize phosphorylated tyrosines. One suc
h cytoplasmic effector molecule is the phosphatidylinositol-3-phosphat
e kinase (PI3 kinase) which recognizes the motif phosphotyrosine - met
hione/valine - X - methionine (X being any amino acid) within the cyto
plasmic tails of numerous receptor tyrosine kinases. As CD28 contains
a copy of the Pl3 kinase binding motif within its cytoplasmic tall, we
investigated CD28 signaling and Pl3 kinase activation. Here we demons
trate using the Jurkat cell line that CD28 becomes tyrosine phosphoryl
ated following CD28 cross-linking and associates with Pl3 kinase. Furt
hermore, a synthetic peptide representing the YM/VXM motif within the
cytoplasmic tail of CD28 also interacts with Pl3 kinase only when the
tyrosine is phosphorylated. CD28 co-stimulation, therefore, similar to
that of CD19 and 'co-stimulation' of B cells travel in part via the a
ctivation of the Pl3 kinase pathway.